Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.530
-0.170 (-10.00%)
At close: Jun 27, 2025, 4:00 PM
1.620
+0.090 (5.88%)
After-hours: Jun 27, 2025, 6:52 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $45.54 million as of June 27, 2025. Its market cap has decreased by -72.54% in one year.
Market Cap
45.54M
Enterprise Value
45.23M
1-Year Change
-72.54%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $45.54M, a decrease of -78.03%. That is a compound annual growth rate of -67.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 52.38M | -57.27% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.64B |
| Johnson & Johnson | 366.49B |
| AbbVie | 327.94B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 274.09B |
| Abbott Laboratories | 239.12B |
| Novartis AG | 231.01B |
| AstraZeneca | 218.32B |